Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Asian Pac J Cancer Prev. 2012;13(9):4465-8.

Lack of association of glutathione S-transferase M3 gene polymorphism with the susceptibility of lung cancer.

Author information

  • 1Department of Cardio-Thoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, NanNing, China.

Abstract

OBJECTIVE:

The conclusions of published reports on the relationship between the glutathione S-transferase M3 (GSTM3) A/B gene polymorphism and the risk of lung cancer are still debated. This meta-analysis was performed to evaluate the association between GSTM3 and the risk of lung cancer.

METHODS:

Association investigations were identified from PubMed, Embase, and Cochrane Library, and eligible studies were included and synthesized using a meta-analysis method.

RESULTS:

Eight reports were included into this meta-analysis for the association of GSTM3 A/B gene polymorphism and lung cancer susceptibility, covering 1,854 patients with lung cancer and 1,926 controls. No association between the GSTM3 A/B gene polymorphism and lung cancer was found in this meta-analysis (B allele: OR = 1.25, 95% CI: 0.89-1.76, P = 0.20; BB genotype: OR = 1.53, 95% CI: 0.71-3.32, P = 0.28; AA genotype: OR = 0.85, 95% CI: 0.59-1.23, P = 0.39).

CONCLUSIONS:

The GSTM3 A/B gene polymorphism is not associated with lung cancer susceptibility. However, more studies on the relationship between GSTM3 A/B gene polymorphism and the risk of lung cancer should be performed in the future.

PMID:
23167362
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Asian Pacific Organization for Cancer Prevention
    Loading ...
    Write to the Help Desk